Showing 1 to 1 of 1 results
bbc.com
🌐 85% Global Worthiness
UK Drug Approval Delays Cause Anxiety for Patients
Mike Thomas, diagnosed with MND in 2022, is experiencing slowed deterioration thanks to tofersen via an early access program; however, the drug's uncertain NHS future and differing access across the UK (exemplified by Sara and David's situations with omaveloxolone) highlight challenges in the nation...
UK Drug Approval Delays Cause Anxiety for Patients
Mike Thomas, diagnosed with MND in 2022, is experiencing slowed deterioration thanks to tofersen via an early access program; however, the drug's uncertain NHS future and differing access across the UK (exemplified by Sara and David's situations with omaveloxolone) highlight challenges in the nation...
Progress
48% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results